Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From genome to lifestyle: adaptive strategies of <i>Pseudomonas</i> sp. AU10 and its Antarctic lineage.

Applied and environmental microbiology·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage.

Scientific reports·2025
Same author

Biochemical features and biotechnological potential of a proteolytic extract from a psychrophilic Antarctic bacterium.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2025
Same author

Kraft lignin biobleaching by a dye-decolorizing peroxidase from the Antarctic Pseudomonas sp. AU10 strain.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2024
Same author

XylR regulates genes at xyl cluster, involved in D-xylose catabolism in Herbaspirillum seropedicae Z69.

Archives of microbiology·2024

Related Experiment Video

Updated: Jun 13, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Violacein as a multitarget agent in bladder cancer cells.

Juan F Idiarte1, Lucía Canclini2, Diego Alem2

  • 1Bioquímica, Departamento de Biología Celular y Molecular, Instituto de Biología, Facultad de Ciencias, Universidad de la República, Igua 4225. 11400, Montevideo, Uruguay.

Journal of Proteomics
|June 11, 2026
PubMed
Summary

The bacterial pigment violacein shows anticancer effects by altering the tumor microenvironment and boosting immune responses in bladder cancer cells. It may improve patient prognosis by targeting multiple cancer pathways.

Keywords:
Anticancer agentBladder cancer cellsDifferential proteomicsViolacein

More Related Videos

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

Related Experiment Videos

Last Updated: Jun 13, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Violacein, a bacterial pigment, exhibits anticancer properties.
  • Previous studies demonstrated its antiproliferative effects on cervical and bladder cancer cells.

Purpose of the Study:

  • To investigate the molecular mechanisms of violacein's anticancer activity in T24 bladder cancer cells.
  • To identify key proteins and pathways modulated by violacein using quantitative proteomics and qRT-PCR.

Main Methods:

  • Quantitative differential proteomics was performed on T24 bladder cancer cells treated with violacein.
  • Quantitative real-time PCR (qRT-PCR) was used to validate gene expression changes.
  • Proteomic data was analyzed to identify proteins involved in cancer-related pathways.

Main Results:

  • Violacein treatment led to the overproduction of proteins involved in tumor microenvironment remodeling, cell adhesion, immune response, apoptosis, autophagy, and cell cycle arrest.
  • ICAM-1 showed significant gene and protein overexpression, suggesting a role in enhancing immune cell infiltration.
  • Violacein reduced Annexin levels, potentially limiting tumor promotion and metastasis.

Conclusions:

  • Violacein acts as a multitarget agent, modulating various cancer-related pathways.
  • ICAM-1 is identified as a key mediator of violacein's anticancer effects.
  • Violacein's modulation of the tumor microenvironment and immune response suggests potential for improved bladder cancer patient prognosis.